KLDO
Vanguard Group’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-870,602
| Closed | -$1.44M | – | 4684 |
|
|
2022
Q1 | $1.44M | Sell |
870,602
-166,785
| -16% | -$275K | ﹤0.01% | 4085 |
|
|
2021
Q4 | $2.48M | Buy |
1,037,387
+967
| +0.1% | +$2.31K | ﹤0.01% | 3963 |
|
|
2021
Q3 | $5.66M | Buy |
1,036,420
+8,965
| +0.9% | +$49K | ﹤0.01% | 3575 |
|
|
2021
Q2 | $7.64M | Buy |
1,027,455
+41,286
| +4% | +$307K | ﹤0.01% | 3352 |
|
|
2021
Q1 | $7.99M | Buy |
986,169
+336,414
| +52% | +$2.72M | ﹤0.01% | 3279 |
|
|
2020
Q4 | $5.91M | Buy |
649,755
+102,844
| +19% | +$936K | ﹤0.01% | 3285 |
|
|
2020
Q3 | $6.05M | Buy |
546,911
+1,530
| +0.3% | +$16.9K | ﹤0.01% | 3051 |
|
|
2020
Q2 | $4.05M | Buy |
545,381
+206,332
| +61% | +$1.53M | ﹤0.01% | 3196 |
|
|
2020
Q1 | $2.09M | Buy |
339,049
+576
| +0.2% | +$3.54K | ﹤0.01% | 3300 |
|
|
2019
Q4 | $1.7M | Buy |
338,473
+21,649
| +7% | +$109K | ﹤0.01% | 3493 |
|
|
2019
Q3 | $2.39M | Buy |
316,824
+225,359
| +246% | +$1.7M | ﹤0.01% | 3390 |
|
|
2019
Q2 | $1.06M | Buy |
+91,465
| New | +$1.06M | ﹤0.01% | 3661 |
|